Cargando…
PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation
BACKGROUND: Interleukin-6 (IL-6) has been demonstrated to be a critical factor for breast cancer malignancy. However, the molecular mechanisms by which IL-6 induce breast cancer cells epithelial–mesenchymal-transition (EMT) and stemness remain elusive. METHODS: Breast cancer cell lines T47D and MCF7...
Autores principales: | Gao, Xueqiang, Liu, Xiangping, Lu, Yangyong, Wang, Yu, Cao, Weihong, Liu, Xiaoyi, Hu, Haiyan, Wang, Haibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694096/ https://www.ncbi.nlm.nih.gov/pubmed/30989585 http://dx.doi.org/10.1007/s12282-019-00966-3 |
Ejemplares similares
-
The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas
por: Forshell, Linus Plym, et al.
Publicado: (2011) -
PIM-1 modulates cellular senescence and links IL-6 signaling to heterochromatin formation
por: Jin, Bo, et al.
Publicado: (2014) -
Pim1 promotes cell proliferation and regulates glycolysis via interaction with MYC in ovarian cancer
por: Wu, Yong, et al.
Publicado: (2018) -
Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
por: Wang, Jie, et al.
Publicado: (2010) -
Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells
por: Wang, Jie, et al.
Publicado: (2011)